ReviewCancer management and research2023

Targeted Treatment of Relapsed or Refractory Follicular Lymphoma: Focus on the Therapeutic Potential of Mosunetuzumab.

Paolo Lopedote et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.